Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Correlation of various lipid-lowering and hypoglycemic drugs with the risk of gastric cancer in elderly population

Zhiye Zhang¹, Wenzhong Xu², Liang Fang³, Shuangshuang Guo¹

¹Henan Key Laboratory of Cancer Epigenetics; Cancer Institute, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471000, China; ²Department of Neurosurgery, Second Affiliated Hospital, Luoyang 471000, China; ³Department of Anesthesiology, Second Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471000, China.

For correspondence:- Shuangshuang Guo Email: guoshuangshuangg@126.com

Accepted: 23 June 2023 Published: 31 July 2023

Citation: Zhang Z, Xu W, Fang L, Guo S. Correlation of various lipid-lowering and hypoglycemic drugs with the risk of gastric cancer in elderly population. Trop J Pharm Res 2023; 22(7):1503-1510 doi: 10.4314/tjpr.v22i7.21

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the correlation between several lipid-lowering and hypoglycemic drugs and the risk of gastric cancer (GC) in elderly population.

Methods: A total of 160 elderly patients with GC who attended The First Affiliated Hospital of Henan University of Science and Technology from January 1, 2014 to December 31, 2020 were enrolled in the study group. Furthermore, 320 healthy volunteers within the same period were assigned to the control group. Clinical data (such as history of statin, sulfonylurea and biguanide administration) were collected from the patient’s medical records. Multifactorial logistic regression was used to determine the association between these lipid-lowering and glucose-lowering drugs, and the risk of developing GC.

Results: After adjusting for numerous confounding factors, multifactorial logistic regression showed that long-term use (>12 months of treatment) of statins and biguanides significantly reduced the risk of GC in elderly population (p = 0.006, p = 0.004, respectively), while long-term use of sulphonylureas increased the risk of GC in elderly population (p = 0.004).

Conclusion: Statins, sulfonylureas and biguanides may be closely associated with the development of GC in elderly population. Therefore, a detailed understanding of the efficacy and mechanisms of action of these drugs may benefit the elderly in the prevention and control of GC.

Keywords: Gastric cancer, Statins, Sulfonylureas, Biguanides, Association